Anti-trypanosomatid activity of ceragenins

Journal of Parasitology

Volumn 96, Issue 3, 2010, Pages 638-642

  Lara, Diana ^a   Feng, Yanshu ^a,b   Bader, Julia ^a   Savage, Paul B ^a   Maldonado, Rosa A ^a  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

^b Brigham Young University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CERAGENIN; STEROID; UNCLASSIFIED DRUG;

ANTIBIOTICS; CHEMOTHERAPY; HYPOTHESIS TESTING; PARASITIC DISEASE; PROTOZOAN;

ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; LEISHMANIA MAJOR; MACROPHAGE; MAMMAL CELL; MOUSE; NONHUMAN; TRYPANOSOMA; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

ANALYSIS OF VARIANCE; ANIMALS; CELL LINE; CELLS, CULTURED; LEISHMANIA MAJOR; LETHAL DOSE 50; MACACA MULATTA; MACROPHAGES; MICE; STEROIDS; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

LEISHMANIA MAJOR; MAMMALIA; TRYPANOSOMA CRUZI; TRYPANOSOMATIDAE;

EID: 77953827385     PISSN: 00223395     EISSN: 19372345     Source Type: Journal    
DOI: 10.1645/GE-2329.1     Document Type: Article

References (37)

1. ACOSTA-SERRANO, A., C. HUTCHINSON, E. S. NAKAYASU, I. C. ALMEIDA, AND M. CARRINGTON. 2007. Comparison and evolution of the surface architecture of trypanosomatid parasites. In Trypanosomes: After the genome, J. D. Barry, J. C. Mottram, R. McCulloch, and A. Acosta-Serrano (eds.). Horizon Scientific Press, Norwich, U.K., p. 319-337.
2. ALBEROLA, J., A. RODRIGUEZ, O. FRANCINO, X. ROURA, L. RIVAS, AND D. ANDREU. 2004. Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis. Antimicrobial Agents and Chemotherapy 48: 641-643.
3. ANDREWS, N. W., AND W. COLLI. 1982. Adhesion and interiorization of Trypanosoma cruzi in mammalian cells. Journal of Protozoology 29: 264-269.
4. BANULS, A. L., M. HIDE, AND F. PRUGNOLLE. 2007. Leishmania and the leishmaniases: A parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans. Advances in Parasitology 64: 1-109.
5. BERA, A., S. SINGH, R. NAGARAJ, AND T. VAIDYA. 2003. Induction of autophagic cell death in Leishmania donovani by antimicrobial peptides. Molecular and Biochemical Parasitology 127: 23-35.
6. BOULANGER, N., R. J. MUNKS, J. V. HAMILTON, F. VOVELLE, R. BRUN, M. J. LEHANE, AND P. BULET. 2002. Epithelial innate immunity. A novel antimicrobial peptide with antiparasitic activity in the blood-sucking insect Stomoxys calcitrans. Journal Biological Chemistry 277: 49921-49926.
7. CHIN, J. N., M. J. RYBAK, C. M. CHEUNG, AND P. B. SAVAGE. 2007. Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 51: 1268-1273.
8. DIAZ-ACHIRICA, P., J. UBACH, A. GUINEA, D.ANDREU, AND L. RIVAS. 1998. The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide. Biochemical Journal 330 (Pt 1): 453-460.
9. DING, B., N. YIN, Y. LIU, J. CARDENAS-GARCIA, R. EVANSON, T. ORSAK, M. FAN, G. TURIN, AND P. B. SAVAGE. 2004. Origins of cell selectivity of cationic steroid antibiotics. The Journal of the American Chemical Society 126: 13642-13648.
10. DOBARRO, D., C. GOMEZ-RUBIN, A. SANCHEZ-RECALDE, F.OLIAS, M. BRETZURITA, E. CUESTA-LOPEZ, A. ROBLES-MARHUENDA, J. M. FRAILEVICENTE, J. R. PANO-PARDO, AND J. LOPEZ-SENDON. 2008. Chagas' heart disease in Europe: An emergent disease? Journal of Cardiovascular Medicine (Hagerstown) 9: 1263-1267.
11. DUsCHAK, V. G., AND A. S. COUTO. 2007. An insight on targets and patented drugs for chemotherapy of Chagas' disease. Recent Patents on Anti-Infective Drug Discovery 2: 19-51.
12. EPAND, R. M., R. F. EPAND, AND P. B. SAVAGE. 2008. Ceragenins (cationic steroid compounds), a novel class of antimicrobial agents. Drug News and Perspectives 21: 307-311.
13. FERGUSON, M. A. J. 1999. The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. Journal of Cell Science 112 (Pt 17): 2799-2809.
14. GUHA-NIYOGI, A., D. R. SULLIVAN, AND S. J. TURCO. 2001. Glycoconjugate structures of parasitic protozoa. Glycobiology 11: 45R-59R.
15. INCE, C., P. C. LEIJH, J. MEIJER, E. VAN BAVEL, AND D. L. YPEY. 1984. Oscillatory hyperpolarizations and resting membrane potentials of mouse fibroblast and macrophage cell lines. Journal of Physiology 352: 625-635.
16. KIRCHHOFF, L. V., AND R. D. PEARSON. 2007. The emergence of Chagas' disease in the United States and Canada. Current Infectious Disease Reports 9: 347-350.
17. MALDONADO, R. A., J. MOLINA, G. PAYARES, AND J. A. URBINA. 1993. Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease. Antimicrobial Agents and Chemotherapy 37: 1353-1359.
18. MARIN-NETO, J. A., A. RASSI, JR., A. AVEZUM, JR., A. C. MATTOS, AND A. RASSI. 2009. The BENEFIT trial: Testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas' heart disease. Memorias Instituto do Oswaldo Cruz 104 (Suppl 1): 319-324.
19. MCGWIRE, B. S., C. L. OLSON, B. F. TACK, AND D. M. ENGMAN. 2003. Killing of African trypanosomes by antimicrobial peptides. The Journal of Infectious Diseases 188: 146-152.
20. MENDONCA-PREVIATO, L., A. R. TODESCHINI, N.HEISE, AND J. O. PREVIATO. 2005. Protozoan parasite-specific carbohydrate structures. Current Opinion in Structural Biology 15: 499-505.
21. MURTA, S. M., AND A. J. ROMANHA. 1998. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole. Parasitology 116 (Pt 2): 165-171.
22. OLESEN, S. P., P. F. DAVIES, AND D. E. CLAPHAM. 1988. Muscarinicactivated K+ current in bovine aortic endothelial cells. Circulation Research 62: 1059-1064.
23. PEREIRA-CHIOCCOLA, V. L., A. ACOSTA-SERRANO, I. CORREIA DE ALMEIDA, M. A. FERGUSON, T. SOUTO PADRON, M. M. RODRIGUES, L. R. TRAVASSOS, AND S. SCHENKMAN. 2000. Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies. Journal of Cell Science 113 (Pt 7): 1299-1307.
24. PETIT, C., V. YARDLEY, F. GABORIAU, J. BOLARD, AND S. L. CROFT. 1999. Activity of a heat-induced reformulation of amphotericin B deoxycholate (fungizone) against Leishmania donovani. Antimicrobial Agents and Chemotherapy 43: 390-392.
25. POLONIO, T., AND T. EFFERTH. 2008. Leishmaniasis: Drug resistance and natural products (review). International Journal of Molecular Medicine 22: 277-286.
26. ROBERTS, C. W., R.MCLEOD, D.W.RICE, M.GINGER, M. L.CHANCE, AND L. J. GOAD. 2003. Fatty acid and sterol metabolism: Potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa. Molecular and Biochemical Parasitology 126: 129-142.
27. SAVAGE, P. B., C. LI, U. TAOTAFA, B. DING, AND Q. GUAN. 2002. Antibacterial properties of cationic steroid antibiotics. FEMS Microbiology Letters 217: 1-7.
28. SILVA, P. I., JR., S. DAFFRE, AND P. BULET. 2000. Isolation and characterization of gomesin, an 18 residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family. Journal of Biological Chemistry 275: 33464-33470.
29. SINGH, S., AND R. SIVAKUMAR. 2004. Challenges and new discoveries in the treatment of leishmaniasis. Journal of Infection and Chemotherapy 10: 307-315.
30. TARLETON, R. L., R. REITHINGER, J. A. URBINA, U. KITRON, AND R. E. GURTLER. 2007. The challenges of Chagas disease-Grim outlook or glimmer of hope. PLoS Medicine 4: e332.
31. TURCO, S. J., AND A. DESCOTEAUX. 1992. The lipophosphoglycan of Leishmania parasites. Annual Review of Microbiology 46: 65-94.
32. URBINA, J. A. 1997. Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites. Parasitology 114 (Suppl): S91-S99.
33. -. 2002. Chemotherapy of Chagas' disease. Current Pharmaceutical Design 8: 287-295.
34. -, K. LAZARDI, E.MARCHAN, G. VISBAL, T. AGUIRRE, M. M. PIRAS, R. PIRAS, R. A. MALDONADO, G. PAYARES, AND W. DE SOUZA. 1993. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: In vitro and in vivo studies. Antimicrobial Agents and Chemotherapy 37: 580-591.
35. WASSEF, M. K., T. B. FIORETTI, AND D. M. DWYER. 1985. Lipid analyses of isolated surface membranes of Leishmania donovani promastigotes. Lipids 20: 108-115.
36. WHO. 2002. Control of Chagas disease. World Health Organization Technical Reports Series 905: 24-28.
37. WILKINSON, S. R., AND KELLY, J. M. 2009. Trypanocidal drugs: Mechanisms, resistance and new targets. Expert Reviews in Molecular Medicine 11: e31.